Pilot Study to Evaluate the Use of Remote Patient Monitoring to Guide the Timing of Valve Intervention in Patients with Severe Asymptomatic Aortic Stenosis (APRAISE-AS): Study Protocol for a Randomised Controlled Trial Delivered in Two Tertiary...

Overview

Journal BMJ Open

Specialty General Medicine

Date 2024 Jun 10

PMID 38858149

Authors

Nazish Khan

Richard P Steeds

Derek Kyte

Larissa Fabritz

Philip Collis

Winnie Chua

Clive Stubbs

Samir Mehta

Yongzhong Sun

Mary Nulty

Katie Kirkham

James M Cotton

Affiliations

Soon will be listed here.

Abstract

Introduction: Aortic stenosis (AS) is common affecting >13% of adults over the age of 75 years. In people who develop symptoms, without valve replacement, prognosis is dismal with mortality as high as 50% at 1 year. In asymptomatic patients, the timing of valve intervention is less well defined and a strategy of watchful waiting is recommended. Many, however, may develop symptoms and attribute this to age related decline, rather than worsening AS. Timely intervention in asymptomatic severe AS is critical, since delayed intervention often results in poor outcomes. Proactive surveillance of symptoms, quality of life and functional capacity should enable timely identification of people who will benefit from aortic valve replacement. There are no data however, to support the clinical and cost effectiveness of such an approach in a healthcare setting in the UK. The aim of this pilot trial is to test the feasibility of a full-scale randomised controlled trial (RCT) to determine the utility of proactive surveillance in people with asymptomatic severe AS to guide the timing of intervention.

Methods And Analysis: APRAISE-AS is a multi-centre, non-blinded, two-arm, parallel group randomised controlled trial of up to 66 participants aged >18 years with asymptomatic severe AS. Participants will be randomised to either standard care or standard care supplemented with the APRAISE-AS intervention. Primary outcomes will capture; adherence to and participant acceptability of the intervention, recruitment and retention rates, and completeness of data collection. The findings will be used to inform the sample size and most appropriate outcome measure(s) for a full-scale RCT and health economic evaluation.

Ethics And Dissemination: Ethical approval was granted by the Black Country REC, reference: 22/WM/0214. Results will be submitted for publication in peer-reviewed journals and disseminated at local, regional and national meetings where appropriate.

Trial Registration Number: ISRCTN19413194 registered on 14.07.2023.

References

Genereux P, Schwartz A, Oldemeyer B, Cohen D, Redfors B, Prince H . Design and rationale of the evaluation of transcatheter aortic valve replacement compared to surveillance for patients with asymptomatic severe aortic stenosis: The EARLY TAVR trial. Am Heart J. 2023; 268:94-103. DOI: 10.1016/j.ahj.2023.11.019. View

Leon M, Smith C, Mack M, Miller D, Moses J, Svensson L . Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363(17):1597-607. DOI: 10.1056/NEJMoa1008232. View

Kwok C, Bagur R, Rashid M, Lavi R, Cibelli M, de Belder M . Aortic stenosis and non-cardiac surgery: A systematic review and meta-analysis. Int J Cardiol. 2017; 240:145-153. DOI: 10.1016/j.ijcard.2017.04.037. View

Browne R . On the use of a pilot sample for sample size determination. Stat Med. 1995; 14(17):1933-40. DOI: 10.1002/sim.4780141709. View

Kappetein A, Head S, Genereux P, Piazza N, Van Mieghem N, Blackstone E . Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J. 2012; 33(19):2403-18. DOI: 10.1093/eurheartj/ehs255. View

Everett R, Clavel M, Pibarot P, Dweck M . Timing of intervention in aortic stenosis: a review of current and future strategies. Heart. 2018; 104(24):2067-2076. PMC: 6287563. DOI: 10.1136/heartjnl-2017-312304. View

Tribouilloy C, Rusinaru D, Bohbot Y, Marechaux S, Vanoverschelde J, Enriquez-Sarano M . How Should Very Severe Aortic Stenosis Be Defined in Asymptomatic Individuals?. J Am Heart Assoc. 2019; 8(3):e011724. PMC: 6405579. DOI: 10.1161/JAHA.118.011724. View

Otto C . Valvular aortic stenosis: disease severity and timing of intervention. J Am Coll Cardiol. 2006; 47(11):2141-51. DOI: 10.1016/j.jacc.2006.03.002. View

Bing R, Everett R, Tuck C, Semple S, Lewis S, Harkess R . Rationale and design of the randomized, controlled Early Valve Replacement Guided by Biomarkers of Left Ventricular Decompensation in Asymptomatic Patients with Severe Aortic Stenosis (EVOLVED) trial. Am Heart J. 2019; 212:91-100. DOI: 10.1016/j.ahj.2019.02.018. View

10.

Rosenhek R, Zilberszac R, Schemper M, Czerny M, Mundigler G, Graf S . Natural history of very severe aortic stenosis. Circulation. 2009; 121(1):151-6. DOI: 10.1161/CIRCULATIONAHA.109.894170. View

11.

Afilalo J, Lauck S, Kim D, Lefevre T, Piazza N, Lachapelle K . Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study. J Am Coll Cardiol. 2017; 70(6):689-700. DOI: 10.1016/j.jacc.2017.06.024. View

12.

Arnold S, OBrien S, Vemulapalli S, Cohen D, Stebbins A, Brennan J . Inclusion of Functional Status Measures in the Risk Adjustment of 30-Day Mortality After Transcatheter Aortic Valve Replacement: A Report From the Society of Thoracic Surgeons/American College of Cardiology TVT Registry. JACC Cardiovasc Interv. 2018; 11(6):581-589. PMC: 5868746. DOI: 10.1016/j.jcin.2018.01.242. View

13.

Lancaster G, Dodd S, Williamson P . Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004; 10(2):307-12. DOI: 10.1111/j..2002.384.doc.x. View

14.

Sepehri A, Beggs T, Hassan A, Rigatto C, Shaw-Daigle C, Tangri N . The impact of frailty on outcomes after cardiac surgery: a systematic review. J Thorac Cardiovasc Surg. 2014; 148(6):3110-7. DOI: 10.1016/j.jtcvs.2014.07.087. View

15.

Chan A, Tetzlaff J, Gotzsche P, Altman D, Mann H, Berlin J . SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013; 346:e7586. PMC: 3541470. DOI: 10.1136/bmj.e7586. View

16.

Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J . 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg. 2021; 60(4):727-800. DOI: 10.1093/ejcts/ezab389. View

17.

Chan A, Tetzlaff J, Altman D, Laupacis A, Gotzsche P, Krleza-Jeric K . SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013; 158(3):200-7. PMC: 5114123. DOI: 10.7326/0003-4819-158-3-201302050-00583. View

18.

Osnabrugge R, Mylotte D, Head S, Van Mieghem N, Nkomo V, LeReun C . Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013; 62(11):1002-12. DOI: 10.1016/j.jacc.2013.05.015. View

19.

Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K . Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis. J Am Coll Cardiol. 2015; 66(25):2827-2838. DOI: 10.1016/j.jacc.2015.10.001. View